These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 6324182)
1. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Weller PF; Lee CW; Foster DW; Corey EJ; Austen KF; Lewis RA Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7626-30. PubMed ID: 6324182 [TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. Henderson WR; Harley JB; Fauci AS Immunology; 1984 Apr; 51(4):679-86. PubMed ID: 6323307 [TBL] [Abstract][Full Text] [Related]
3. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187. Dessein AJ; Lee TH; Elsas P; Ravalese J; Silberstein D; David JR; Austen KF; Lewis RA J Immunol; 1986 May; 136(10):3829-38. PubMed ID: 3009610 [TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia. Laviolette M; Picard S; Braquet P; Borgeat P Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C. Cromwell O; Shaw RJ; Walsh GM; Mallet AI; Kay AB Int J Immunopharmacol; 1985; 7(5):775-81. PubMed ID: 2995265 [TBL] [Abstract][Full Text] [Related]
7. Preferential generation of leukotriene C4 by human eosinophils. Shaw RJ; Cromwell O; Kay AB Clin Exp Immunol; 1984 Jun; 56(3):716-22. PubMed ID: 6086189 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and release of leukotriene C4 by human eosinophils. Owen WF; Soberman RJ; Yoshimoto T; Sheffer AL; Lewis RA; Austen KF J Immunol; 1987 Jan; 138(2):532-8. PubMed ID: 3025300 [TBL] [Abstract][Full Text] [Related]
9. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate. Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride. Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299 [TBL] [Abstract][Full Text] [Related]
11. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC; Meier KE; Henderson WR J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073 [TBL] [Abstract][Full Text] [Related]
12. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. Tamura N; Agrawal DK; Townley RG J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892 [TBL] [Abstract][Full Text] [Related]
13. Calcium ionophore and chemotactic peptide stimulation of peptidoleukotriene synthesis in DMSO-differentiated HL60 cells. Anthes JC; Bryant RW; Musch MW; Ng K; Siegel MI Inflammation; 1986 Jun; 10(2):145-56. PubMed ID: 3011668 [TBL] [Abstract][Full Text] [Related]
14. Effects of exogenous eicosapentaenoic acid on generation of leukotriene C4 and leukotriene C5 by calcium ionophore-activated human eosinophils in vitro. Thien FC; Hallsworth MP; Soh C; Lee TH J Immunol; 1993 Apr; 150(8 Pt 1):3546-52. PubMed ID: 8468488 [TBL] [Abstract][Full Text] [Related]
16. Specific leukotriene formation by purified human eosinophils and neutrophils. Verhagen J; Bruynzeel PL; Koedam JA; Wassink GA; de Boer M; Terpstra GK; Kreukniet J; Veldink GA; Vliegenthart JF FEBS Lett; 1984 Mar; 168(1):23-8. PubMed ID: 6323218 [TBL] [Abstract][Full Text] [Related]
17. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. Williams JD; Lee TH; Lewis RA; Austen F J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages. Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187. Roubin R; Elsas PP; Fiers W; Dessein AJ Clin Exp Immunol; 1987 Nov; 70(2):484-90. PubMed ID: 2827923 [TBL] [Abstract][Full Text] [Related]
20. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]